These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 22795895)

  • 1. Costimulatory activation of murine invariant natural killer T cells by toll-like receptor agonists.
    Kulkarni RR; Villanueva AI; Elawadli I; Jayanth P; Read LR; Haeryfar SM; Sharif S
    Cell Immunol; 2012; 277(1-2):33-43. PubMed ID: 22795895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of marginal zone B lymphocytes in invariant NKT cell activation.
    Bialecki E; Paget C; Fontaine J; Capron M; Trottein F; Faveeuw C
    J Immunol; 2009 May; 182(10):6105-13. PubMed ID: 19414762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.
    Hogan AE; O'Reilly V; Dunne MR; Dere RT; Zeng SG; O'Brien C; Amu S; Fallon PG; Exley MA; O'Farrelly C; Zhu X; Doherty DG
    Clin Immunol; 2011 Aug; 140(2):196-207. PubMed ID: 21493160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invariant NKT cell anergy is induced by a strong TCR-mediated signal plus co-stimulation.
    Iyoda T; Ushida M; Kimura Y; Minamino K; Hayuka A; Yokohata S; Ehara H; Inaba K
    Int Immunol; 2010 Nov; 22(11):905-13. PubMed ID: 21118907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential indirect activation of human invariant natural killer T cells by Toll-like receptor agonists.
    Moreno M; Mol BM; von Mensdorff-Pouilly S; Verheijen RH; de Jong EC; von Blomberg BM; van den Eertwegh AJ; Scheper RJ; Bontkes HJ
    Immunotherapy; 2009 Jul; 1(4):557-70. PubMed ID: 20635987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG oligonucleotide-mediated co-stimulation of mouse invariant natural killer T cells negatively regulates their activation status.
    Kulkarni RR; Villanueva AI; Read LR; Brisbin JT; Bhaumik SK; LaMarre J; Murali-Krishna K; Sharif S
    Cell Tissue Res; 2017 Sep; 369(3):541-554. PubMed ID: 28550425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD3γ-independent pathways in TCR-mediated signaling in mature T and iNKT lymphocytes.
    Reiné J; Busto EM; Muñoz-Ruiz M; Rossi NE; Rodríguez-Fernández JL; Martínez-Naves E; Regueiro JR; Recio MJ
    Cell Immunol; 2011; 271(1):62-6. PubMed ID: 21764047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated iNKT cells promote Vγ9Vδ2-T cell anti-tumor effector functions through the production of TNF-α.
    Schneiders FL; de Bruin RC; Santegoets SJ; Bonneville M; Scotet E; Scheper RJ; Verheul HM; de Gruijl TD; van der Vliet HJ
    Clin Immunol; 2012 Feb; 142(2):194-200. PubMed ID: 22122798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine-dependent modification of IL-12p70 and IL-23 balance in dendritic cells by ligand activation of Valpha24 invariant NKT cells.
    Uemura Y; Liu TY; Narita Y; Suzuki M; Nakatsuka R; Araki T; Matsumoto M; Iwai LK; Hirosawa N; Matsuoka Y; Murakami M; Kimura T; Hase M; Kohno H; Sasaki Y; Ichihara Y; Ishihara O; Kikuchi H; Sakamoto Y; Jiao SC; Senju S; Sonoda Y
    J Immunol; 2009 Jul; 183(1):201-8. PubMed ID: 19542431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
    Wu L; Gabriel CL; Parekh VV; Van Kaer L
    Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminobisphosphonates inhibit dendritic cell-mediated antigen-specific activation of CD1d-restricted iNKT cells.
    Schneiders FL; Huijts CM; Mantici A; Menks MA; Scotet E; Veerhuis R; Verheul HM; de Gruijl TD; van der Vliet HJ
    Clin Immunol; 2015 May; 158(1):92-9. PubMed ID: 25796193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of invariant Natural Killer T lymphocytes in response to the α-galactosylceramide analogue KRN7000 encapsulated in PLGA-based nanoparticles and microparticles.
    Macho Fernandez E; Chang J; Fontaine J; Bialecki E; Rodriguez F; Werkmeister E; Krieger V; Ehret C; Heurtault B; Fournel S; Frisch B; Betbeder D; Faveeuw C; Trottein F
    Int J Pharm; 2012 Feb; 423(1):45-54. PubMed ID: 21575695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(I:C) promotes the production of IL-17A by murine CD1d-driven invariant NKT cells in airway inflammation.
    Vultaggio A; Nencini F; Pratesi S; Petroni G; Romagnani S; Maggi E
    Allergy; 2012 Oct; 67(10):1223-32. PubMed ID: 22882449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of invariant natural killer T cells by α-galactosylceramide ameliorates myocardial ischemia/reperfusion injury in mice.
    Homma T; Kinugawa S; Takahashi M; Sobirin MA; Saito A; Fukushima A; Suga T; Takada S; Kadoguchi T; Masaki Y; Furihata T; Taniguchi M; Nakayama T; Ishimori N; Iwabuchi K; Tsutsui H
    J Mol Cell Cardiol; 2013 Sep; 62():179-88. PubMed ID: 23774048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cell function can be modulated through cooperative actions of TLR ligands and invariant NKT cells.
    Hermans IF; Silk JD; Gileadi U; Masri SH; Shepherd D; Farrand KJ; Salio M; Cerundolo V
    J Immunol; 2007 Mar; 178(5):2721-9. PubMed ID: 17312114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cigarette smoke alters the invariant natural killer T cell function and may inhibit anti-tumor responses.
    Hogan AE; Corrigan MA; O'Reilly V; Gaoatswe G; O'Connell J; Doherty DG; Lynch L; O'Shea D
    Clin Immunol; 2011 Sep; 140(3):229-35. PubMed ID: 21684213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of decidual invariant natural killer T cells promotes lipopolysaccharide-induced preterm birth.
    Li L; Yang J; Jiang Y; Tu J; Schust DJ
    Mol Hum Reprod; 2015 Apr; 21(4):369-81. PubMed ID: 25589517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfatide inhibits α-galactosylceramide presentation by dendritic cells.
    Kanamori M; Tasumi Y; Iyoda T; Ushida M; Inaba K
    Int Immunol; 2012 Feb; 24(2):129-36. PubMed ID: 22247226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor agonists and invariant natural killer T-cells enhance antibody-dependent cell-mediated cytotoxicity (ADCC).
    Moreno M; Mol BM; von Mensdorff-Pouilly S; Verheijen RH; von Blomberg BM; van den Eertwegh AJ; Scheper RJ; Bontkes HJ
    Cancer Lett; 2008 Dec; 272(1):70-6. PubMed ID: 18684557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered invariant natural killer T cell subsets and its functions in patients with oral squamous cell carcinoma.
    Singh AK; Shukla NK; Das SN
    Scand J Immunol; 2013 Nov; 78(5):468-77. PubMed ID: 23980793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.